• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health to Host Symposium in Hopes of Increasing HPV Vaccination Rates in Maryland 
    The HPV vaccine is the first vaccine to prevent cancer
    Baltimore, MD (February 29, 2018) — The Maryland Department of Health will be hosting a Human Papillomavirus Vaccination (HPV) symposium titled, Providers Are the Key on Saturday, March 3. The symposium will feature local and national experts on HPV, HPV-associated cancers, and HPV vaccination best practices.
    As one of the key evidence-based approaches to prevent cancer, the HPV vaccine is an effective intervention; however, rates of vaccinations continue to be low in Maryland. Thus, this symposium is aimed at educating providers on the importance of the vaccine, as well as arming them with tools and conversation to increase awareness among their patients (and patients' parents). Providers from across the state are expected to attend this important event.
    HPV is a group of more than 150 related viruses, and nearly everyone will be infected with at least one type of HPV at some point during his/her lifetime. In most cases, HPV infections go away on their own and do notcause health problems. However, some HPV infections do not go away, and these cause certain cancers, such as cervical, vaginal, penile, anal, and oropharyngeal. Every year, HPV causes 30,700 cancers in men and women in the United States.
    “Research has shown that parents get their children vaccinated against HPV when their doctor makes a balanced recommendation and explains the vaccine to them,” said Department Public Health Deputy SecretaryDr. Howard Haft. “This symposium is an opportunity for Maryland providers to learn more about HPV vaccination as a way to protect their patients against certain cancers.”
    The HPV vaccine offers protection against the types of HPV that commonly cause cancers. In clinical trials that led to the approval of the vaccine, the vaccine was found to provide nearly 100 percent protection against persistent cervical infections with HPV types 16 and 18 — the HPV types most associated with cervical cancer. Studies involving other HPV-associated cancers have also shown the vaccine to be highly effective.
    The Centers for Disease Control and Prevention (CDC) recommends the HPV vaccine be given to 11- to 12-year-old boys and girls, so they are protected before ever being exposed to the virus. CDC’s National Immunization Survey (NIS-Teen) from 2016 indicates that only 54 percent of girls and 45 percent of boys in Maryland are up-to-date with their HPV vaccination.